Overexpression of her2/neu, estrogen and progesterone receptors in invasive micropapillary carcinoma of the breast

被引:10
|
作者
Kuroda H. [1 ]
Sakamoto G. [3 ]
Ohnisi K. [2 ]
Itoyama S. [1 ]
机构
[1] Department of Pathology, Saitama Medical Center, Saitama Medical School, Kawagoe, Saitama 350-8550, 1981, Tsujido, Kamoda
[2] Department of Surgery, Saitama Medical Center, Saitama Medical School
[3] Department of Breast Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research
关键词
Breast carcinoma; ER; Her2/neu protein; Invasive micropapillary carcinoma; PgR;
D O I
10.1007/BF02984553
中图分类号
学科分类号
摘要
Background: Invasive micropapillary carcinoma (IMC) of the breast is a rare subtype of breast carcinoma that has an extremely high incidence of lymph node metastasis and poor clinical outcome. Furthermore, there has been interest in the prognostic markers related to the biological characteristics of breast carcinoma, such as the status of Her2/neu, estrogen receptor (ER) and progesterone receptor (PgR). Materials and Methods: We reviewed 671 cases of primary breast carcinoma which were surgically resected between 1990 and 2003. Of these, 27 cases of invasive ductal carcinoma of the breast with a pure or partial micropapillary component were reported. Tests for Her2/neu protein, estrogen receptor (ER) and progesterone receptor (PgR) were performed on paraffin sections. The relationship among these markers was analyzed and statistical significance determined by chi-square test. Conclusion: The rate of Her2/neu protein overexpression, ER and PgR status was quite similar to those of common breast carcinomas.
引用
收藏
页码:301 / 305
页数:4
相关论文
共 50 条
  • [1] Prevalence of androgen receptors in invasive breast carcinoma and its relation with estrogen receptor, progesterone receptor and Her2/neu expression
    Alshenawy, Hanan AlSaeid
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2012, 24 (02) : 77 - 83
  • [2] EXPRESSION OF ESTROGEN, PROGESTERONE AND HER2/NEU RECEPTORS IN BREAST CARCINOMA: STUDY IN A TERTIARY CARE HOSPITAL
    Deshpande, Ashok Kumar
    Erukkambattu, Jayashankar
    Prabhala, Shailaja
    Tanikella, Ramamurti
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2015, 4 (58): : 10170 - 10177
  • [3] HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma
    Perron, Marjorie
    Wen, Hannah Y.
    Hanna, Matthew G.
    Brogi, Edi
    Ross, Dara S.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (08) : 979 - 987
  • [4] Expression of estrogen and progesterone receptors and Her2/Neu oncogene in breast carcinoma: Correlation between cytologic and surgical specimens
    Sullivan, KE
    Cohen, C
    Chakraborty, H
    Battles, OE
    MODERN PATHOLOGY, 2001, 14 (01) : 63A - 63A
  • [5] The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast
    Latta, EK
    Tjan, S
    Parkes, RK
    O'Malley, FP
    MODERN PATHOLOGY, 2002, 15 (12) : 1318 - 1325
  • [6] Immunohistochemical assessment of estrogen, progesterone receptors and HER2/neu overexpression by core needle biopsy in a sample of Iraqi breast cancer patients
    Mohammed, Dahlia Raouf
    Alwan, Nada A. S.
    Hussein, Raji
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2019, 5 (04): : 214 - 217
  • [7] Breast Carcinoma, Receptor Status, and Her2 neu Overexpression Revisited
    Puvitha, R. D.
    Shifa, S.
    INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 2016, 3 (10) : 52 - 58
  • [8] Status of estrogen, progesterone and her-2/neu receptors in breast cancer
    Lumturije, G.
    Kushtrim, S. H.
    Rame, A.
    Adriatik, K.
    Esat, B.
    Ardita, K.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 87 - 87
  • [9] Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas)
    Lerma, Enrique
    Peiro, Gloria
    Ramon, Teresa
    Fernandez, Sonia
    Martinez, Daniel
    Pons, Cristina
    Munoz, Fina
    Sabate, Josep Ma
    Alonso, Carmen
    Ojeda, Belen
    Prat, Jaime
    Barnadas, Agusti
    MODERN PATHOLOGY, 2007, 20 (11) : 1200 - 1207
  • [10] Prognostic in estrogen, progesterone and her-2/neu negative invasive breast carcinomas
    Ricketts-Loriaux, R. S.
    Otis, C. N.
    Resetkova, E.
    Sneige, N.
    LABORATORY INVESTIGATION, 2007, 87 : 47A - 48A